Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

June 25, 2024

Study Completion Date

June 25, 2024

Conditions
HemodialysisEnd Stage Renal Disease Requiring Hemodialysis
Interventions
BEHAVIORAL

Pharmacist led behavioral change technique

"The intervention was developed based on the behavior change technique taxonomy (v1). This intervention was designed to improve adherence to all therapeutic aspects of hemodialysis patients, including the dialysis program, medications, diet, and fluids. Additionally, the effect of the pharmacist intervention on physiological indices (serum potassium, total calcium, phosphate, IDWG, and hemoglobin) was examined.~The program was explicitly created for implementation in an actual setting, ensuring that the time allocation for participants and facilitators (the party responsible for conducting the PL-BCT) remained reasonable in most contexts.~The BCT components were developed after the identification and coding of the BCTs from previous interventional studies that contain behavioral components and result in positive effects on one or more hemodialysis patients' adherence domains toward their therapeutic regimen (dialysis program, medications, diet, and fluid)."

Trial Locations (1)

10047

Baghdad Medical City, Baghdad

All Listed Sponsors
lead

Thuraya Safaa Ibrahim

OTHER

NCT06744738 - Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence | Biotech Hunter | Biotech Hunter